Unlocking the Potential of High-Quality Dopamine Transporter Pharmacological Data: Advancing Robust Machine Learning-Based QSAR Modeling
Abstract
The dopamine transporter (DAT) plays a critical role in the central nervous system and has been implicated in numerous psychiatric disorders. The ligand-based approaches are instrumental to decipher the structure-activity relationship (SAR) of DAT ligands, especially the quantitative SAR (QSAR) modeling. By gathering and analyzing data from literature and databases, we systematically assemble a diverse range of ligands binding to DAT, aiming to discern the general features of DAT ligands and uncover the chemical space for potential novel DAT ligand scaffolds. The aggregation of DAT pharmacological activity data, particularly from databases like ChEMBL, provides a foundation for constructing robust QSAR models. The compilation and meticulous filtering of these data, establishing high-quality training datasets with specific divisions of pharmacological assays and data types, along with the application of QSAR modeling, prove to be a promising strategy for navigating the pertinent chemical space. Through a systematic comparison of DAT QSAR models using training datasets from various ChEMBL releases, we underscore the positive impact of enhanced data set quality and increased data set size on the predictive power of DAT QSAR models.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 7.13
- Field percentile
- top 3%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Using QSAR for predictions in drug delivery
E. Rivera-Delgado, A. Xin, H. von Recum·bioRxiv·Aug 6, 2019
- Exploring the Antidepressant Effects of Saffron Constituents: Targeting Dopamine and Serotonin Transport Proteins, and Monoamine Oxidase-B: An in Silico Evidence-Based Study
Brijendra Bahadur Singh, Deepak sharma, … Vinay Lomash·bioRxiv·Mar 19, 2026
- NeSyDPP4-QSAR: A Neuro-Symbolic AI Approach for Potent DPP-4-Inhibitor Discovery in Diabetes Treatment
Delower Hossain, Ehsan Saghapour, Jake Y. Chen·bioRxiv·Mar 31, 2025
- Cocaine and caffeine elicit different dopamine receptor-mediated locomotor activity profiles: insights from a new model.
Jordan Moass, Krithik Ashokkumar, Martin O. Job·bioRxiv·Jan 14, 2026
- DrugForm-DTA: Towards real-world drug-target binding Affinity Model
Ivan Khokhlov, Anna S. Tashchilova, … Veronika Igorevna Skvortsova·Computational and Structural Biotechnology JournalPeer-reviewed·Jan 1, 2025
- Structural Insights into Dopamine Receptor-Ligand Interactions: From Agonists to Antagonists
E. Barbosa, H. Clift, … W. Liu·bioRxiv·Nov 3, 2023